CAR-NK cell therapy combined with checkpoint inhibition induces a NKT cell response in glioblastoma

被引：0

作者：

Strassheimer, Florian ^{[1
,2
,3
,4
]}

Elleringmann, Philipp ^{[1
,2
,3
,4
]}

Roller, Bastian ^{[1
,2
,3
,4
]}

Macas, Jadranka ^{[2
,5
]}

Alekseeva, Tijna ^{[2
,6
]}

Aliraj, Blerina ^{[2
,7
]}

Weber, Katharina ^{[2
,3
,4
,5
]}

Demes, Melanie ^{[8
]}

Tonn, Torsten ^{[9
]}

Reib, Yvonne ^{[2
,3
,4
,5
]}

Plate, Karl ^{[2
,3
,4
,5
]}

Weigert, Andreas ^{[2
,3
,4
,7
]}

Wels, Winfried ^{[2
,3
,4
,6
]}

Steinbach, Joachim ^{[1
,2
,3
,4
]}

Burger, Michael ^{[1
,2
,3
,4
]}

机构：

[1] Goethe Univ Frankfurt, Univ Hosp, Dr Senckenberg Inst Neurooncol, Frankfurt, Germany

[2] Goethe Univ Frankfurt, Frankfurt Canc Inst FCI, Frankfurt, Germany

[3] German Canc Consortium DKTK, Heidelberg, Germany

[4] German Canc Res Ctr, Heidelberg, Germany

[5] Goethe Univ Frankfurt, Univ Hosp, Inst Neurol, Edinger Inst, Frankfurt, Germany

[6] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany

[7] Goethe Univ Frankfurt, Inst Biochem 1, Frankfurt, Germany

[8] Goethe Univ Frankfurt, Univ Hosp, Dr Senckenberg Inst Pathol, Frankfurt, Germany

[9] Goethe Univ Frankfurt, Inst Transfus Med & Immune Hematol, German Red Cross Blood Donat Serv Baden Wurttembe, Frankfurt, Germany

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

1921 - WS4

引用

页码：302 / 302

页数：1

共 50 条

[1] CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma
Strassheimer, F.
Elleringmann, P.
Ludmirski, G.
Roller, B.
Macas, J.
Alekseeva, T.
Cakmak, P.
Aliraj, B.
Krenzlin, H.
Demes, M. C.
Mildenberger, I. C.
Tonn, T.
Weber, K. J.
Reiss, Y.
Plate, K. H.
Weigert, A.
Wels, W. S.
Steinbach, J. P.
Burger, M. C.
BRITISH JOURNAL OF CANCER, 2025,
[2] CAR-NK cell therapy for glioblastoma: what to do next?
Xiong, Qi
Zhu, Jiao
Zhang, Yong
Deng, Hongxin
FRONTIERS IN ONCOLOGY, 2023, 13
[3] Advances in CAR-NK cell therapy for hematological malignancies
Yang, Rui
Yang, Yun
Liu, Rui
Wang, Yiwen
Yang, Ruoyu
He, Aili
FRONTIERS IN IMMUNOLOGY, 2024, 15
[4] CAR-NK cell therapy: a potential antiviral platform
Lin, Ming-Hao
Hu, Li-Juan
Miller, Jeffrey S.
Huang, Xiao-Jun
Zhao, Xiang-Yu
SCIENCE BULLETIN, 2025, 70 (05) : 765 - 777
[5] Armored CAR-NK Cell Therapy for Ovarian Cancer
Krueger, Joshua B.
Chang, Jae Woong
Vue, Young
Gilkey, Alexandria
Folsom, Timothy
Niemeyer, Ethan
Skeate, Joseph
Webber, Beau
Moriarity, Branden S.
MOLECULAR THERAPY, 2024, 32 (04) : 839 - 839
[6] Avoiding CAR-NK cell fratricide
Lucia Brunello
Nature Cancer, 2022, 3 : 1445 - 1445
[7] Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Valeri, Antonio
Garcia-Ortiz, Almudena
Castellano, Eva
Cordoba, Laura
Maroto-Martin, Elena
Encinas, Jessica
Leivas, Alejandra
Rio, Paula
Martinez-Lopez, Joaquin
FRONTIERS IN IMMUNOLOGY, 2022, 13
[8] Avoiding CAR-NK cell fratricide
Brunello, Lucia
NATURE CANCER, 2022, 3 (12) : 1445 - 1445
[9] NK cells in renal cell carcinoma and its implications for CAR-NK therapy
Li, Xinwei
Zhang, Yuanpeng
Ye, Yuzhong
Xiao, Wen
Liu, Lei
Zhang, Xiaoping
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2025, 13
[10] ESTABLISHMENT OF CAR-NK CELL THERAPY TARGETING B7-H3 AGAINST GLIOBLASTOMA
Tachi, Tetsuro
Kijima, Noriyuki
Kuroda, Hideki
Ikeda, Shunya
Murakami, Koki
Hirayama, Ryuichi
Okita, Yoshiko
Kagawa, Naoki
Hosen, Naoki
Kishima, Haruhiko
NEURO-ONCOLOGY, 2023, 25

← 1 2 3 4 5 →